Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study

Manayesh Bantie Tadie,Yimer Seid Yimer,Girma Taye
DOI: https://doi.org/10.1136/bmjopen-2023-083076
IF: 3.006
2024-05-25
BMJ Open
Abstract:Objective It was necessary to understand the determinants of severe COVID-19 in order to deliver targeted healthcare services to prevent further complications and mortality. Identifying the factors associated with severe COVID-19 in Addis Ababa, Ethiopia, is the aim of this study. Design A case–control study was conducted from October 2021 to March 2022. Setting The study was conducted at three public COVID-19 treatment centres including Ekka Kotebe General, St. Peter Hospital and St. Paul's Hospital. Participants The study participants were COVID-19 patients admitted to three COVID-19 treatment centres. Cases were patients admitted with severe COVID-19, and controls were patients with mild or moderate COVID-19. A total of 306 patients (153 cases and 153 controls) selected by simple random sampling technique participated in this study. Outcome measures and analysis Data were collected by a face-to-face or telephone interviewer using a structured questionnaire. COVID-19 admission category, clinical and biomedical characteristics and comorbidity-related data were extracted from the participant's medical record. Multivariable binary logistic regression analysis was used to identify predictors of COVID-19 severity. Results The odds of being old were 4.54 times higher among severe COVID-19 cases (adjusted odds ratio (AOR)=4.54, 95% CI=2.499 to 8.24), the odds of being male were 2.72 times higher among severe COVID-19 cases (AOR=2.72, 95% CI=1.46 to 5.057), being vaccinated for COVID-19 decreases the severity by 55.1% (AOR=0.449, 95% CI=0.251 to 0.801), having good knowledge about COVID-19 decreases by 65% (AOR=0.35%, 95% CI=0.195 to 0.63) among patients with severe COVID-19, the odds of being diabetic were 10.2 times higher among severe COVID-19 cases (AOR=10.2, 95% CI=4.596 to 22.61) and the odds of being hypertensive were 2.3 times higher among severe COVID-19 cases (AOR=2.26, 95% CI=1.092 to 4.685). Conclusion Male, older age, diabetes or hypertension comorbidity, COVID-19 vaccination and having inadequate knowledge about COVID-19 were determinant factors of severe COVID-19.
medicine, general & internal
What problem does this paper attempt to address?
The paper aims to explore and identify the factors leading to severe COVID-19 in Ethiopia. The study employs a case-control design and is conducted in three public COVID-19 treatment centers in Addis Ababa, the capital of Ethiopia, spanning from October 2021 to March 2022. The study participants include COVID-19 patients treated at these three centers, divided into a severe case group (153 cases) and a non-severe or mild case group (153 cases). A total of 306 patients were selected to participate in the study through random sampling. The main study results indicate: - Patients aged ≥50 years have a 4.54 times higher risk of developing severe COVID-19 compared to younger patients. - Male patients have a 2.72 times higher risk of developing severe COVID-19 compared to female patients. - Patients who have been vaccinated against COVID-19 have a 55.1% lower likelihood of developing severe disease. - Patients with good knowledge of COVID-19 have a 65% lower likelihood of developing severe disease. - Patients with diabetes have a 10.2 times higher risk of developing severe COVID-19 compared to those without diabetes. - Patients with hypertension have a 2.26 times higher risk of developing severe COVID-19 compared to those without hypertension. In conclusion, this study identifies several factors associated with severe COVID-19, including age, gender, vaccination status, level of knowledge about the disease, and underlying conditions such as diabetes or hypertension. These findings are significant for guiding medical interventions targeted at specific risk groups.